Stem Cell Theory of Carcinogenesis -Classical and Most Recent Evidence

Similar documents
Stem Cell:The Promise and The Challenge

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

A disease of populations of cells that live, divide, invade and spread without regard to normal limits

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5

Leukemias and Lymphomas: A primer

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Cancer: DNA Synthesis, Mitosis, and Meiosis

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

How To Expand Hematopoietic Stem Cells

Immunohistochemical differentiation of metastatic tumours

in silico hematology

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

CHAPTER 2: UNDERSTANDING CANCER

The Biological Basis of Cancer. Annie Young, Professor of Nursing, University of Warwick, University Hospitals Coventry and Warwickshire

Types of Cancers [-oma growth ]!

How CanCer becomes critical in the claims

Stem Cells: The Real Culprits in Cancer?

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base

Clinical Cancer Research: Alternative IRB Models and Enhancing Progress

4.1 3T12 and 312 are immortalized cell lines with transforming potential:

Biochemistry of Cancer Cell

EDUCATIONAL COMMENTARY - GRANULOCYTE FORMATION AND CHRONIC MYELOCYTIC LEUKEMIA

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

PART 3.3: MicroRNA and Cancer

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

CHARACTERISTIC FEATURES OF STEM CELLS. CLONING TECHNOLOGIES

PREPARED FOR: U.S. Army Medical Research and Materiel CommandFort Detrick, Maryland

An Introduction to Stem Cell Biology. Michael L. Shelanski, MD,PhD Professor of Pathology and Cell Biology Columbia University

Relative Risk (Sokal & Hasford): Relationship with Treatment Results. Michele Baccarani

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed

Endocrine factors influencing melanoma progression

ACUTE MYELOID LEUKEMIA (AML),

guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research

Breast cancer and the role of low penetrance alleles: a focus on ATM gene

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

CML. cure. A Patient s Guide. Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More

Stem Cell Therapy In Diabetes Mellitus. Professor Megahid Abuelmagd Diabetes And Endocrine Unit. Mansoura Faculty Of Medicine

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Report series: General cancer information

Genes and Cancer. What are genes? Dominant vs. recessive genes

# Circuits relevant to cancer, related to known TFs.

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA

A disease and antibody biology approach to antibody drug discovery

New Hampshire Childhood Cancer

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

Malignant Lymphomas and Plasma Cell Myeloma

Cancer can occur at almost any organ in the body

Clonetics Conditionally Immortalized Human Cells. Relevant Cells for High Throughput Screening

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

Shantaram S. Joshi, Ph.D.

Oncology Best Practice Documentation

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Co-pay assistance organizations offering assistance

Cytotoxic and Biotherapies Credentialing Programme Module 2

Immunohistochemistry of soft tissue tumors

STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Settore Scientifico disciplinare MED. 13/ENDOCRINOLOGIA

Breast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.

March 19, Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith,

Cell Division Mitosis and the Cell Cycle

Fulfilling the Promise

Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia

Human Genome Organization: An Update. Genome Organization: An Update

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking

Unit 1 Higher Human Biology Summary Notes

MUTATION, DNA REPAIR AND CANCER

Chapter 16 Reproductive Technology, Gene Therapy, and Stem Cells (modified)

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)

Biotechnology. Srivatsan Kidambi, Ph.D.

Human Papillomavirus Infection and Oropharyngeal Cancer

Head of College Scholars List Scheme. Summer Studentship. Report Form

Molekylært målrettet medicinsk kræftbehandling for klinikere principper og metoder

Chemotherapy resistance in acute myeloid leukemia: the role of adhesion

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

Myeloid Leukemias - Current and Future Approaches to Targeted and Individualized Therapies

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

New strategies in anticancer therapy

The Immune System: A Tutorial

Introduction to Pathology and Diagnostic Medicine

What is chronic myeloid leukaemia?

The Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative

5 Frequently Asked Questions About Adult Stem Cell Research

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

7.012 Quiz 3 practice

16.40 Tumor - A New Generation of Cancer Biologics

An Overview of Cells and Cell Research

STEM CELL FELLOWSHIP

INTERNATIONAL COURSE:

Cancer causes about one-fifth of the deaths in the

Transcription:

Stem Cell Theory of Carcinogenesis -Classical and Most Recent Evidence Chia-Cheng Chang, Ph.D. Dept. Pediatrics and Human Development Michigan State University

The Origin of Undifferentiated State of Tumor Cells The relatively undifferentiated state of certain tumor cells is reminiscent of the state of embryonic cells prior to their specialization during development. Gene and the Biology of Cancer Harold Varmus and Robert A. Weinberg

The Origin of Undifferentiated State of Tumor Cells 1.Dedifferentiation 2.Blocked differentiation of stem cells

Cancer is : a disease of cell differentiation (Markert, 1968). oncogeny as blocked or partially blocked ontogeny (Potter, 1978). a disease of the pluripotent stem cell (Sawyers et al., 1991).

Chronic Myelogenous Leukemia (CML) t(9:22) Philadelphia chromosome hybrid mrna and protein with tyrosine kinase activity (bcr-abl, p210)

CML is a disease of the pluripotent stem cell The Philadelphia chromosome is found in all hematopoietic lineages in patients with this malignancy, but not in skin fibroblasts or bone marrow stromal cells. Sawyers et al. Cell 64:337-350, 1991

Acute Myeloid Leukaemia (AML) The most frequent chromosomal abnormalities in AML involve the 8; 21 translocation, which results in AML1-ETO chimaeric transcripts in leukaemia cells. In patients in remission, the AML1-ETO transcripts were found in a fraction of normal HSCs in the marrow, indicating that the translocation occurred originally in normal HSC and that additional mutations subsequently lead to leukaemia. (CD34 + Cd38 - Thy-1 + CD34 + Cd38 - Thy-1 - ) Miyamoto, T et al, Proc. Natl. Acad. Sci. USA 97: 7521-7526, 2000.

B-Cell Non-Hodgkin s Lymphoma t (14:18) translocation in all hematopoietic cell lineage S. Yarkoni et al. (J. Nat. Cancer Inst., 88: 973-9, 1996)

Cancer Instances in Large and Small Intestines Small Intestines Large Intestines 350 new cases/year 28,600 new cases/year

The Role of Bcl-2 in Maintaining Stem Cell Integrity The anti-apoptotic gene bcl-2 is expressed at the base of murine and human colonic crypts, whereas expression is not seen in the small intestine, supporting the view that bcl-2 increases the apoptotic threshold of colonic stem cells. Merritt et al., J. Cell Sci. 108:2261-2271, 1995

Location of apoptotic cells following cytotoxic exposure Small intestine---at stem cell position High frequency (altruistic suicide) Large intestine---not limited to stem cell position Low frequency

Pregnancy and Reduced Risk of Breast Cancer 1. Decreased stem cell multiplication (John Cairns,1975) 2. Induced differentiation of mammary gland (L.H. Russo et al., 1990)

Three Lobule Types of Breast Tissue Lobule 1 Lobule 2 Lobule 3

Terminal End Buds of Mammary Gland as Major Target for Carcinogenesis Carcinogen acts on the TEB and that this structure is the one that evolves to intraductal proliferation, carcinoma in situ, and invasive carcinoma. I.H. Russo and J. Russo Environ. Health Perspectives 104:938-967, 1996

High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization W. Sun, K.S. Kang, I. Morita, J.E. Trosko and C.C. Chang Cancer Res. 59 : 6118-6123, 1999.

Function of SV40 Large T-antigen 1.Inactivating p53 and prb. 2.Inducing a CCAAT box binding factor which transactivates cyclin A, cdc2, DNA polymerase α, thymidine kinase etc.

Major Events in Carcinogenesis (1) Altered cell cycle regulation bypassing cellular senescence. (2) Telomerase activation immortalization (3) Activation of a growth-promoting pathway tumorigenic (4) Altered cell adhesion, mobility and protease/collagenase activity invasion and metastasis.

A Nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. R.Y.L. Tsai and R. D.G. McKay Genes and Development 16: 2991-3003, 2002.

Nucleostemin A novel protein containing an N-terminal basic domain and two GTP-binding domain. Function : regulate cell proliferation, differentiation, apoptosis in a p53-dependent manner. Found in the nucleoli of CNS stem cells, embryonic stem cells and several cancer cell lines. When stem cells differentiate, nucleostemin expression decreases rapidly.

Gap Junctional Intercellular Communication of HL1-1 Cell Line

GJIC in L1SV1 Cells

GJIC in Heptoma Cells

Current Opinion in Cell Biology 1998; 10:710

Vimentin and α-foetoprotein are collectively termed the oval cell phenotype

Expression of Vimentin in HL1-1 Cell Line

Expression of Vimentin in L1SV1 Cells

Expression of Alpha Foetoprotein in HL1-1 Cell Line

Expression of Alpha Foetoprotein in L1SV1 Cells

Anchorage Independent Growth of HL1-1 Cell Line AIG = 4.6% Colony forming efficiency on plastic = 11%

Similarity Between Putative Human Liver Stem Cells and Hepatocellular Carcinoma Deficient in gap junctional intercellular communicatioon Expression of Vimentin Expression alpha foetoprotein Ability of anchorage independent growth

Similarity of Stem Cells and Tumor Cells 1.Deficient in gap junctional intercellular communication. 2.Ability of anchorage independent growth. 3.Similar phenotypes of human breast epithelial stem cells and breast cancer cells CX26 -, α-6 integrin -, maspin -, estrogen receptor (ER + ).

Similarity of Stem Cells and Tumor Cells 4.Nucleostemin, a novel protein found in the nucleoli of CNS stem cells, embryonic stem cells and several cancer cell lines. When stem cells differentiate, nucleostemin expression decrease rapidly prior to cell-cycle exit both in vitro and in vivo. 5.Expression of alpha foetoprotein and vimetin in liver stem cells and liver tumor cells 6..Contact-insensitive growth (e.g. kidney epithelial stem cells)

These results are consistent with Oncogeny as blocked or partially blocked ontogeny theory ------- by Van R. Potter and The stem cell theory of carcinogenesis

Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis G.H. Lee Toxicologic Pathology 28 : 215-225, 2000

Protocol One--Postweaning

Protocol Two--Postweaning

Protocol Three--Preweaning

Discussion

Discussion

Why Stem Cells Are Key Target Cells for Carcinogenesis 1.Stem cells express many tumor cell phenotypes, fewer mutations or epigenetic alterations may be required for tumor progression. Human embryonic stem cells are immortal and tumorigenic (teratoma) 2.Stem cells have unlimited or extended lifespan, there is a much greater opportunity for mutations to accumulate. Human breast epithelial stem cells are more susceptible to telomerase activation and immortalization. Stem cells of large intestine have higher threshold for apoptosis ( bcl-2 expression).

Two Types of Target Cells for Carcinogenesis Liver : Basophilic tumors inhibition by phenobarbital Eosinophilic tumors promotion by phenobarbital Breast : Hormone dependent (ER + ) Vimentin + Cytokeratin 19 - Hormone independent (ER - ) Vimentin - (50%) Cytokeratin 19 + (50%) Prostate : Androgen dependent Androgen independent Skin : Basal cell carcinoma Squamous cell carcinoma

Acknowledgement of Co-Workers Chien-Yuan Kao Ikue Morita Ching-Yi Hsieh Maki Saitoh Jin Lian Tsai Koichiro Nomata Angela Cruz Wei Sun James E. Trosko